This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Fundacao Oswaldo Cruz, Fundacao Oswaldo Cruz-Fiocruz. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Minas Gerais, BR (2011)
- Belo Horizonte, BR (2014)
Company Filing History:
Years Active: 2011-2026
Title: Antoniana Ursine Krettli: Innovator in Pharmaceutical Compounds
Introduction
Antoniana Ursine Krettli is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds derived from artesunate. His work focuses on creating innovative solutions for treating parasitic diseases.
Latest Patents
Krettli holds 3 patents related to compounds derived from artesunate. His latest patents include a detailed description of new compounds represented by a specific general formula. These compounds are designed for use in pharmaceutical compositions aimed at treating or preventing malaria and other parasitic diseases. The inventions also encompass a preparation process for these compounds, highlighting their potential as effective medicines.
Career Highlights
Throughout his career, Antoniana has worked with esteemed institutions such as the Oswaldo Cruz Foundation. His research has contributed to advancements in the pharmaceutical field, particularly in the development of antiparasitic medications. His innovative approach has garnered attention and respect within the scientific community.
Collaborations
Krettli has collaborated with notable colleagues, including Marcus Vinicius Nora De Souza and Alessandra Leda Valverde. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Antoniana Ursine Krettli's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to the development of new compounds for treating parasitic diseases highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile